Elfin Pharma Private Limited, a active private limited company, was established on 14 July 1999 in Punjab, Punjab, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231PB1999PTC022779. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.96 M.
It upholds a compliant status. Its leadership includes Gurinder Kaur Makkar (Director), Manpreet Kaur (Whole-Time Director), Dilpreet Singh (Managing Director). Past directors included Shashi Kumar Sahai, Abhey Pal Singh, Harsimran Kaur Sodhi. It holds ₹7.15 Cr open charges and ₹17.23 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E 206 Phase Viii Bbindustrial Area Focal Point Sas Nagar, Punjab, Punjab.
U24231PB1999PTC022779
022779
14 July 1999
₹2.00 M
₹1.96 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Elfin Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gurinder Kaur Makkar | Director | 28 Apr 2004 | Current |
| Manpreet Kaur | Whole-Time Director | 15 Feb 2001 | Current |
| Dilpreet Singh | Managing Director | 15 Feb 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Oct 2012 | Past |
| Pramod Abcsdd | Director | 05 Oct 2012 | Past |
| Pramod Abcsdd | Director | 05 Oct 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elfin Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 45.61% increase. The company also saw a substantial improvement in profitability, with a 52.29% increase in profit. The company's net worth Soared by an impressive increase of 22.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Elfin Pharma had a public holding of 0.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹71,500,000.00
₹172,290,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jul 2012 | The Karur Vysya Bank Limited | ₹1.20 M | Open |
| 21 Feb 2006 | Oriental Bank Of Commerce | ₹5.54 Cr | Open |
| 27 Nov 2002 | State Bank Of Patiala | ₹5.40 M | Open |
| 27 Nov 2002 | State Bank Of Patala | ₹6.50 M | Open |
| 27 Nov 2002 | State Bank Of Patiala | ₹3.00 M | Open |
Explore comprehensive loan charge details -
Elfin Pharma has a workforce of 0 employees as of Oct 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Elfin Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elfin Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Elfin Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Elfin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was documented.
Progress on A charge registered on 15 Jan 2022 via Charge ID 100534663 with Hdfc Bank Limited was fully satisfied on 01 Feb 2024. was documented.
The activity A charge with Hdfc Bank Limited of Rs. 104.61 M registered on 15 Jan 2022 with Charge ID 100534663 was modified on 01 May 2023. was completed.
A charge registered on 28 Jun 2016 via Charge ID 100047326 with Others was fully satisfied on 23 Apr 2022. was recorded as a recent event.
The activity A charge registered on 08 Oct 2015 via Charge ID 10606453 with Aditya Birla Finance Limited was fully satisfied on 23 Apr 2022. was completed.
The CIN of Elfin Pharma Private Limited is U24231PB1999PTC022779.
Elfin Pharma Private Limited is headquartered at E 206 Phase Viii Bbindustrial Area Focal Point Sas Nagar, Punjab, Punjab.
Elfin Pharma Private Limited was incorporated on 14 July 1999.
The current directors of Elfin Pharma Private Limited are
The primary industry of Elfin Pharma Private Limited is Manufacturing.
Elfin Pharma Private Limited is unlisted.
The authorized capital of Elfin Pharma Private Limited is ₹2.00 M, and the paid-up capital is ₹1.96 M.
The compliance status of Elfin Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX